Aveanna Healthcare (NASDAQ:AVAH) Issues Quarterly Earnings Results

Posted by Francis Steltz on May 14th, 2026

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05, FiscalAI reports. Aveanna Healthcare had a net margin of 9.25% and a return on equity of 481.69%. The company had revenue of $647.92 million during the quarter, compared to the consensus estimate of $613.22 million. The business’s quarterly revenue was up 15.9% on a year-over-year basis.

Here are the key takeaways from Aveanna Healthcare’s conference call:

Aveanna posted strong Q1 results with revenue of about $648 million, up 15.9% year over year, and adjusted EBITDA of $84.4 million, up 25.2%, driven by better rates, higher volumes, and operational efficiencies.
The company raised full-year 2026 guidance to revenue of $2.56 billion-$2.58 billion and adjusted EBITDA of $328 million-$332 million, excluding the pending Family First acquisition.
Preferred payer strategy continues to gain traction across all businesses, with 4 new PDS preferred payer agreements, 4 new Home Health agreements, and 2 new Medical Solutions agreements in Q1.
Management said the new CMS Home Health moratorium should not affect Aveanna or its Family First acquisition, and it does not change the company’s 2026 or 2027 business plans.
Balance sheet and cash generation remain solid, with liquidity of about $525 million and net leverage at 3.8x, while management reiterated a path toward further deleveraging alongside tuck-in acquisitions.

Aveanna Healthcare Trading Up 9.9%

Shares of Aveanna Healthcare stock traded up $0.67 during trading hours on Thursday, hitting $7.44. The company’s stock had a trading volume of 4,276,480 shares, compared to its average volume of 1,274,675. The business has a fifty day moving average of $6.70 and a 200 day moving average of $7.94. Aveanna Healthcare has a 1-year low of $3.73 and a 1-year high of $10.32. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 6.62. The company has a market capitalization of $1.62 billion, a PE ratio of 7.29 and a beta of 1.93.

Insider Buying and Selling at Aveanna Healthcare

In related news, CFO Matthew Buckhalter sold 13,512 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the sale, the chief financial officer directly owned 529,243 shares of the company’s stock, valued at approximately $3,815,842.03. This represents a 2.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Edwin C. Reisz sold 60,769 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $438,144.49. Following the completion of the transaction, the insider directly owned 1,447,057 shares in the company, valued at $10,433,280.97. This trade represents a 4.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 738,957 shares of company stock worth $5,458,175. Insiders own 5.30% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Police & Firemen s Retirement System of New Jersey increased its stake in Aveanna Healthcare by 37.9% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 17,707 shares of the company’s stock worth $145,000 after buying an additional 4,864 shares during the period. Fox Run Management L.L.C. purchased a new position in Aveanna Healthcare in the 4th quarter valued at about $138,000. Raymond James Financial Inc. grew its stake in shares of Aveanna Healthcare by 287.7% during the third quarter. Raymond James Financial Inc. now owns 17,532 shares of the company’s stock valued at $156,000 after acquiring an additional 13,010 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its stake in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares in the last quarter. Finally, Sei Investments Co. increased its position in shares of Aveanna Healthcare by 71.1% during the second quarter. Sei Investments Co. now owns 29,271 shares of the company’s stock worth $153,000 after acquiring an additional 12,160 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AVAH shares. UBS Group upped their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. Royal Bank Of Canada lowered their price objective on shares of Aveanna Healthcare from $11.00 to $9.00 and set a “sector perform” rating for the company in a research note on Monday, March 23rd. Weiss Ratings lowered Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Truist Financial reduced their target price on Aveanna Healthcare from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, April 13th. Finally, Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $10.25.

View Our Latest Stock Report on Aveanna Healthcare

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Earnings History for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.